معرفی
Riccardo Corbellari is a Research Fellow and Teaching Assistant at the Centre for Medical Sciences (CISMED) at the University of Trento. His expertise spans Cancer Biology, Molecular Biology, Biotechnology, Drug Discovery, and Immunology, with a focus on developing novel therapeutic strategies for cancer and infectious diseases.
He teaches Biologia generale e molecolare, covering Cell Biology and Molecular Biology topics such as cellular structure, genetic mechanisms, protein synthesis, and epigenetics. His research emphasizes tumor-targeted immunotherapies, outer membrane vesicle (OMV)-based vaccines, and engineered antibody-cytokine fusion proteins.
Key research themes include:
- Cancer immunotherapy using immunocytokines and in situ vaccination
- OMV platforms for HPV and SARS-CoV-2 vaccines
- Antibody engineering for targeted drug delivery and immune modulation
- Mechanisms of tumor metastasis and stromal cell interactions
Recent publications highlight advancements in:
- Triokin: a multi-specific immunocytokine for cancer treatment (2025)
- Broadly protective HPV vaccines via OMV platforms (2023)
- Pre-clinical efficacy of OMV-based SARS-CoV-2 vaccines (2023)
- IL-2 and IL-15 fusion proteins for tumor targeting (2020–2023)
No scientific awards are explicitly listed. His work is centered at CISMED, where he contributes to both education and cutting-edge biomedical research.
